Charitable Remainder Trust
A Charitable Remainder Trust is an agreement between you and a trustee that can provide fixed or variable income to meet your specific financial needs, at the termination of which the remaining assets are passed to the AACR Foundation.
A Charitable Remainder Trust provides you and/or another beneficiary(s) with fixed or variable income for life or for a specific period of time and thereafter distributes the remaining assets in the trust to the AACR Foundation. A Charitable Remainder Trust is individually tailored to meet your needs: you can select the beneficiaries, the trustees (including the AACR Foundation), your income rate, and type of trust.
Annual distributions from a Charitable Remainder Unitrust are variable and are based on the value of the principal, re-valued annually. A Charitable Remainder Annuity Trust pays a fixed annual distribution based upon the value of the principal at the time of the gift. Since each trust is individually tailored, there is more flexibility in the type of property that can be donated, including real estate or tax-free municipal bonds.
Use our Planned Giving Calculator. The calculator is designed to provide you with an illustration of the income and tax benefits to which you may be entitled if you establish a charitable remainder trust. Select Charitable Remainder Unitrust from the “gift type” drop-down menu. For proper results, please indicate under “term type” either the birth date(s) of the income beneficiary(ies) or the number of years (up to 20) you wish the trust to last.
To learn more about the American Association for Cancer Research (AACR) and explore which gift option is best for you, contact us today.
The purpose of this web page is to provide information of a general character only. The AACR Foundation is not engaged in rendering legal or tax advisory service. Advice from legal and tax counsel should be sought when considering these types of gifts.
Through planned giving, you can reach your financial goals of today, and give hope for the future of cancer research.